BIOMAT Database Logo BIOMAT Database Logo

Studies on leucomycin. IV. Comparison of leucomycin with erythromycin and carbomycin. 1954

Y SANO, and T HOSHI, and T HATA

UI MeSH Term Description Entries
D007933 Leucomycins An antibiotic complex produced by Streptomyces kitasatoensis. The complex consists of a mixture of at least eight biologically active components, A1 and A3 to A9. Leucomycins have both antibacterial and antimycoplasmal activities.
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D015939 Kitasamycin A macrolide antibiotic produced by Streptomyces kitasatoensis. The drug has antimicrobial activity against a wide spectrum of pathogens. Leucomycin

Related Publications

Y SANO, and T HOSHI, and T HATA
[Clinical experiences with carbomycin and erythromycin].
October 1953, Medicina,
Y SANO, and T HOSHI, and T HATA
Comparison of levels of carbomycin A, carbomycin B, and erythromycin in serum and thyroid tissue.
March 1955, Antibiotic medicine & clinical therapy (New York, NY),
Y SANO, and T HOSHI, and T HATA
Studies on leucomycin A1. IV. Combined effects with sulfa drugs.
January 1966, The Journal of antibiotics,
Y SANO, and T HOSHI, and T HATA
Antimicrobial spectrum and cross resistance studies of erythromycin and carbomycin.
June 1953, Antibiotics & chemotherapy (Northfield, Ill.),
Y SANO, and T HOSHI, and T HATA
Treatment of pneumococcal pneumonia with erythromycin and carbomycin (magnamycin).
September 1953, A.M.A. archives of internal medicine,
Y SANO, and T HOSHI, and T HATA
Studies on leucomycin. III. Experimental treatment in animals with leucomycin.
December 1953, The Journal of antibiotics,
Y SANO, and T HOSHI, and T HATA
Induced resistance of staphylococci to carbomycin and erythromycin.
August 1953, Medical bulletin (Ann Arbor, Mich.),
Y SANO, and T HOSHI, and T HATA
[Laboratory studies on carbomycin].
January 1956, Lijecnicki vjesnik,
Y SANO, and T HOSHI, and T HATA
Clinical studies with carbomycin.
November 1953, The New England journal of medicine,
Y SANO, and T HOSHI, and T HATA
Bacterial spectrum of erythromycin, carbomycin, chloramphenicol, aureomycin, and terramycin.
December 1952, Antibiotics & chemotherapy (Northfield, Ill.),
Copied contents to your clipboard!